CJC-1295 without DAC 5ml + IPA 5ml

CJC-1295 (Without DAC) – 5 mL + IPA 5 mL

CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.

In research environments, CJC-1295 (Without DAC) is studied for its selective interaction with GHRH receptors located in the pituitary axis. These receptors regulate pulsatile growth hormone signaling, making the peptide valuable for examining natural hormone rhythm and feedback mechanisms.

One of the defining characteristics of CJC-1295 without DAC is its rapid clearance compared to long-acting analogs. This allows researchers to investigate acute signaling responses and short-term endocrine dynamics rather than sustained hormonal elevation.

CJC-1295 (Without DAC) is frequently included in studies focused on growth hormone pulse timing and amplitude. Understanding how brief receptor activation influences downstream signaling is a key area of interest in endocrine research.

The peptide is also examined in metabolic signaling research. Growth hormone pathways are closely tied to lipid utilization, protein metabolism, and energy balance, making CJC-1295 relevant for controlled metabolic studies.

Unlike direct growth hormone analogs, CJC-1295 works by stimulating endogenous signaling pathways rather than replacing the hormone itself. This distinction allows researchers to study physiological regulation while maintaining natural feedback loops.

Researchers often use the non-DAC form to compare signaling differences between short-acting and long-acting GHRH analogs. These comparisons help clarify how peptide structure influences duration and intensity of receptor activation.

CJC-1295 (Without DAC) is also studied in gene expression research, where growth hormone–related transcriptional changes are examined following transient signaling events.

The inclusion of IPA (Isopropyl Alcohol) in research kits supports laboratory handling and preparation protocols under controlled conditions. Its presence is intended strictly for research and laboratory use.

The peptide’s predictable molecular behavior supports reproducibility in experimental settings. Consistent receptor interaction allows for reliable comparison across studies.

CJC-1295 (Without DAC) is commonly included in endocrine research that prioritizes physiological accuracy over prolonged stimulation. This makes it useful for studies focused on natural hormonal signaling patterns.

Because growth hormone signaling affects multiple tissues, the peptide is often used in systems-based research rather than isolated pathway analysis.

Its well-characterized structure and short-acting profile make CJC-1295 (Without DAC) a valuable reference compound in growth hormone research.

As interest in peptide-based endocrine investigation continues to expand, CJC-1295 (Without DAC) remains an important tool for studying regulated growth hormone signaling within complex biological systems.